pharma · Intracerebral Hemorrhage
Xuanwu Hospital
Xuanwu Hospital, Beijing
Xuanwu Hospital, Beijing is a pharma organization headquartered in CN. Primary therapeutic focus areas include Intracerebral Hemorrhage. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(
Beijing, CN HQ
117 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Beijing, CN
- Employees
- 117
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Dimethyl fumarate
Phase 2 · small molecule · Intracerebral Hemorrhage
Dimethyl fumarate for Intracerebral Hemorrhage is a Phase 2 program (small_molecule) at Xuanwu Hospital, Beijing with 1 ClinicalTrials.gov record(s).
Internal code haojunwei2
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Xuanwu Hospital, Beijing
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Intracerebral Hemorrhage
- Status
- terminated
- Trials
- 1